Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Advisorshares Psychedelics ETF (NY: PSIL )

1.610 -0.010 (-0.62%)
Official Closing Price Updated: 8:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,147
Open 1.650
Bid (Size) 1.600 (9)
Ask (Size) 1.670 (17)
Prev. Close 1.620
Today's Range 1.600 - 1.650
52wk Range 1.600 - 3.239
Shares Outstanding 41,800
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
September Summary: Largest Psychedelic Drug Stocks Dropped 14%
Seelos Therapeutics' market capitalization dropped below $50M with the recent dramatic decline in its share price and, as such, is no longer part of the Psychedelic Drug Stocks Index. The remaining... 
Via Talk Markets
EXCLUSIVE: What's Next For Cannabis? Industry Experts Discuss Game-Changing New Policies
Cannabis reform has moved one step closer to reality at the federal level on Wednesday, with the Senate Banking Committee approving the Secure and Fair Enforcement Regulation (SAFER) Banking Act. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-15.71%
-15.71%
1 Month
-11.56%
-11.56%
3 Month
-18.68%
-18.68%
6 Month
-12.02%
-12.02%
1 Year
-41.45%
-41.45%

More News

Read More
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Via Benzinga
Topics Economy
Exposures Interest Rates
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
Via Talk Markets
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Via Benzinga
Exposures Product Safety
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
Via Talk Markets
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
Via Talk Markets
6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week
Via Talk Markets
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Via Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
Via Benzinga
The 7 ETFs In The Fringe Portfolio Were, On Average, Up Last Week
Via Talk Markets
Topics Artificial Intelligence Cannabis ETFs
Exposures Artificial Intelligence Cannabis
The Portfolio Of 7 "Fringe" ETFs Is Down 9% MTD; Still Up YTD
Via Talk Markets
Topics Artificial Intelligence Cannabis ETFs
Exposures Artificial Intelligence Cannabis
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
Via Benzinga
Topics Cannabis Economy
Exposures Cannabis Interest Rates
Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend
Via Talk Markets
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Via Benzinga
So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index
Via Talk Markets
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Via Benzinga
These 9 Fringe ETFs Ranged From +23% MTD To -8%
Via Talk Markets
July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%, On Average
Via Talk Markets
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Via Benzinga
These 9 Fringe ETFs Have Outperformed The S&P 500 And Nasdaq
Via Talk Markets
Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More
Via Benzinga
These 8 Fringe ETFs Are Up 5% On Average MTD
Via Talk Markets
Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.